−3.31
Chemomab Therapeutics Ltd.
Metrics score locked — part of Premium
FY21
FY22
FY23
FY24
FY25
FY21 – FY25
(positive)
Change from FY21 to FY25
millions USD
FY21:
FY22:
−5.14
FY23:
−4.39
FY24:
−88.3
FY25:
−102
(positive)
Change from FY21 to FY25
millions USD
FY21:
−15.7
FY22:
−33.7
FY23:
−29.9
FY24:
−103
FY25:
−112
(positive)
Change from FY21 to FY23
millions USD
FY21:
−12.3
FY22:
−28.5
FY23:
−25.4
FY24:
–
FY25:
–
(positive)
Change from FY21 to FY25
millions USD
FY21:
−12.5
FY22:
−28.2
FY23:
−24.2
FY24:
−13.9
FY25:
−9.00
(positive)
Change from FY21 to FY25
millions USD
FY21:
−12.5
FY22:
−27.6
FY23:
−24.2
FY24:
−13.9
FY25:
−9.00
All amounts in millions USD